27-May-2019 | Zion Market Research
Zion Market Research has published a new report titled “Immuno Oncology Assays Market by Product (Consumables and Software), by Assay (Cell Migration & Invasion, Cell Proliferation, Immune Cell Killing, Phagocytosis, and Others), by Technology (PCR, Immunoassay, NGS, Flow Cytometry, and Others), by Indication (Lung Cancer, Colorectal Cancer, Melanoma, Bladder Cancer, and Other Cancers), and by Application (Clinical Diagnostics and Research Applications): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global immuno oncology assays market was approximately USD 2.86 billion in 2018 and is expected to generate around USD 6.63 billion by 2025, at a CAGR of around 12.9% between 2019 and 2025.
Immuno-oncology deals with investigating the body’s immune system in response to cancer cells. Immuno-oncology assays are in-vitro assays that are used to study a drug’s or compound’s response in a tumor’s microenvironment. The worldwide demand for immunology-based oncology assays is growing swiftly, owing to the increasing cancer prevalence, rising acceptance of targeted therapy, and growing demand for monoclonal antibodies (mAb). Additionally, the rising levels of cancer awareness and the increasing number of government initiatives and funding for early cancer diagnosis research are propelling the immuno oncology assays market growth. However, huge capital investments and high immunotherapy treatment cost may restrain the immuno oncology assays market development.
Browse the full “Immuno Oncology Assays Market by Product (Consumables and Software), by Assay (Cell Migration & Invasion, Cell Proliferation, Immune Cell Killing, Phagocytosis, and Others), by Technology (PCR, Immunoassay, NGS, Flow Cytometry, and Others), by Indication (Lung Cancer, Colorectal Cancer, Melanoma, Bladder Cancer, and Other Cancers), and by Application (Clinical Diagnostics and Research Applications): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” Report at https://www.zionmarketresearch.com/report/immuno-oncology-assays-market
The global immuno oncology assays market is fragmented based on product, assay, technology, indication, and application. By product, the market includes consumables (reagents and kits, various accessories, etc.) and software. The consumables segment held the largest market share in 2018, whereas the software segment is expected to show the highest CAGR in the upcoming years. The easy availability of a wide range of reagents and their increasing usage in various cancer therapeutic applications, rapidly growing cancer biomarker research has led to the rising use of consumables.
By assay, the market includes cell migration and invasion, cell proliferation, immune cell killing, phagocytosis, and others. The cell proliferation segment held the largest market share in 2018.
Based on technology, the market includes polymerase chain reaction (PCR), immunoassay, flow cytometry, next-generation sequencing (NGS), and others. The PCR segment held the largest market share in 2018, due to the development of advanced PCR technologies. Additionally, the NGS segment is expected to register the highest CAGR over the forecast time period.
Based on indication, the market includes colorectal cancer, lung cancer, bladder cancer, melanoma, and other cancers. Lung cancer dominated the market in 2018 owing to their high prevalence among all types of cancers.
By application, global immuno oncology assays market is segmented into research applications and clinical diagnostics. Biomarker-based drug development and research and clinical trials are boosting the growth of the research applications segment, whereas the wide adoption of immuno-oncology assays in diagnostics owing to its benefits is driving the demand for clinical diagnostics.
North America dominated the global immuno oncology assays market with a revenue share of almost 40% in 2018. This huge revenue share is accredited to the increasing prevalence of cancer, the presence of advanced healthcare infrastructure, and rising adoption of targeted therapy. North America is estimated to remain at the top market position over the forecast time period as well, owing to the increasing public and private funding for various R&D activities. Europe contributed the second largest revenue share in 2018 to the global immuno oncology assays market, due to rising cancer burden, growing adoption of technologically advanced products, and increasing healthcare spending. The Asia Pacific immuno oncology assays market will register the highest CAGR in the years ahead, owing to the increasing aging population base, rising cancer prevalence, and ongoing cancer therapy clinical trials.
Some major players operating in the global immuno oncology assays market include Thermo Fisher Scientific, Agilent Technologies, Roche Diagnostics, Nanostring Technologies, Illumina, Foundation Medicine, Sartorius, Qiagen, HTG Molecular Diagnostics, PerkinElmer, and Merck.
This report segments the global immuno oncology assays market into:
Global Immuno Oncology Assays Market: By Product
Global Immuno Oncology Assays Market: By Assay
Global Immuno Oncology Assays Market: By Technology
Global Immuno Oncology Assays Market: By Indication
Global Immuno Oncology Assays Market: By Application
Global Immuno Oncology Assays Market: By Region
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651